drugset / Trial / NCT06450197
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomised, double-blind, parallel group, placebo-controlled Phase IIa study designed to evaluate the efficacy and safety of AZD7798 in participants with moderate to severe Crohn's disease.
Timeline
- Start
- 2024-08-28
- Primary completion
- 2026-04-30
- Completion
- 2027-05-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD7798 | Unknown | — | — |